ANNA CLARE VISO: Open Payments
NPI 1750089413 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$410 in 4 payments from 3 companies in 2025. Trend: 2023 $37 · 2024 $39 · 2025 $410
Food & beverage: $410
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $191 |
| GlaxoSmithKline, LLC. | 1 | $122 |
| AERIN MEDICAL INC. | 1 | $96 |
Products named: DUPIXENT, NUCALA, VIVAER STYLUS.
Industry payments across AL — which companies pay providers there.
